Trial Profile
A retrospective study to evaluate safety and efficacy of tocilizumab in patients with rheumatoid arthritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jul 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 15 Jul 2015 New trial record